Abstract

The combination of diabetes mellitus and hypertension increases the chances for progressive renal disorders and ultimately renal failure. Both animal and human studies have investigated this progression, which does not take place in all diabetic patients, but which does inevitably occur in diabetic patients with hypertension or microalbuminuria. In these patients the control of arterial pressure is critical to the preservation of renal function. Certain antihypertensive agents, notably angiotensin converting enzyme inhibitors, verapamil, and diltiazem, seem to combine the required renal and vascular effects most beneficially. This article reviews the research completed so far into these effects. However, long-term studies are needed to consolidate these findings.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.